Vacinação oportuna da série primária da vacina pentavalente no município de Goiânia, Goiás

• Autor(a) principal: Martins, Natália Alves
• Data de Publicação: 2018
• Tipo de documento: Dissertação
• Idioma: por
• Título da fonte: Repositório Institucional da UFG
• dARK ID: ark:/38995/00130000023h6
• Texto Completo: http://repositorio.bc.ufg.br/tede/handle/tede/8954
• topic: Vacina pentavalente; Vacina pneumocócica; Programas de imunização; Vacinação oportuna; Atraso vacinal; DtwP-HepB-Hib vaccine; Pneumococcal vaccines; Immunization programs; Timeliness vaccination; Vaccination delay; IMUNOLOGIA::IMUNOLOGIA APLICADA

INTRODUCTION: Many countries have reported outbreaks of immunopreventable diseases, posing vaccination monitoring at a timely age as a strategic indicator for immunization programs to estimate actual protection. OBJECTIVE: To analyze the timely vaccination of the primary series of the pentavalent vaccine in children under 12 months of age, vaccinated in health units to the Unified Health System. METHODS: A population-based retrospective cohort study with children born in 2014 in the city of Goiânia, Goiás. Data from the Ambulatory Care Control System (SICAA) containing data from vaccines and the Live Birth Information System (SINASC) containing maternal and child data were used. The SICAA and SINASC databases were linked and re-structured through a deterministic linkage to identify the records of the same child. The follow-up time for each child was 365 days after the birth. Only doses and intervals between doses valid for analysis were used. The 10-valent pneumococcal vaccine (PCV10) was used as a vaccine to compare the receipt of the pentavalent vaccine. The timely endpoint vaccination of the three doses in the primary series was defined as the dose of vaccine given up to 30 days of the recommended age. Poisson regression was used to identify predictors of timely vaccination of the primary series of the pentavalent vaccine. RESULTS: Of the 13,523 children included, 77.0% (CI95% 76.3-77.7) and 79.1% (CI95% 78.4-79.8) received three valid doses of the primary series of the pentavalent vaccine and PCV10, respectively. Only 47.1% (95% CI 46.2-48.0) and 47.6% (CI 95% 46.8-48.4) received timely the three doses of pentavalent vaccine and PCV10, respectively. The predictive factors for timely vaccination of the pentavalent primary series and PCV10 were the same: married mother; 7 or more prenatal visits and the mother's age equal to or greater than 20 years. CONCLUSION: Almost 80% of children received valid three primary doses of pentavalent and PCV10 vaccines, but fewer than half of the birth cohort received them on time. New efforts are needed to improve timely vaccination and get the maximum benefit from vaccination.